Latest Articles
-
Buy or Sell Merck Stock?
Merck (MRK) stock has jumped 11% during the past week, and is currently trading at $118.33. We believe there are only a couple of things to fear in MRK stock given its overall Moderate operating performance and financial condition. This is align...
-
Why Merck Stock Jumped 40%?
Merck (MRK) ’s stock skyrocketed 41%, fueled not just by a slight revenue bump but a sharp profit surge and soaring investor confidence. Behind the rally: a blockbuster earnings beat, breakthrough drug approvals, and promising cancer treatment da...
-
Merck Stock Capital Return Hits $91 Bil
In the last decade, Merck (MRK) stock has returned a notable $91 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the market̵...
-
What’s In Store For Merck Stock?
Merck stock jumped over 10% in a month after management dropped a confidence bomb on January 12th. They’re now saying their next-generation drugs—cardiometabolic, respiratory, and infectious disease treatments—will generate $70 billion by t...
-
High Margins, 1.0% Discount: Buy Merck Stock Now
Merck (MRK) stock might be a good buy now. Why? Because you get high margins – reflective of pricing power and cash generation capacity – for a discounted price . Companies like this generate consistent, predictable profits and cash f...
-
Buy or Sell Merck Stock?
Merck (MRK) stock has jumped 10% during the past week, and is currently trading at $104.63. We believe there are only a couple of things to fear in MRK stock given its overall Moderate operating performance and financial condition. This is align...
-
Why Merck Stock Jumped 40%?
Merck (MRK) ’s stock skyrocketed 41%, fueled less by revenue and more by sharper profits and soaring investor confidence. From a pivotal Q3 earnings beat to the FDA nod on Keytruda’s new form and a stellar Wells Fargo upgrade, multiple catalysts ...
-
Merck Stock Now 0.8% Cheaper, Time To Buy
Merck (MRK) stock might be a good buy now. Why? Because you get high margins – reflective of pricing power and cash generation capacity – for a discounted price . Companies like this generate consistent, predictable profits and cash f...
-
Ten-Year Tally: Merck Stock Delivers $91 Bil Gain
In the last decade, Merck (MRK) stock has returned a notable $91 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the market̵...
-
Merck Stock Pricing Powerhouse Now 17% Cheaper, Buy?
Merck (MRK) stock deserves your consideration. Why? Because you get monopoly-like high margins for a discounted price . Here is some data. Revenue Growth : Merck saw growth of 1.8% LTM and 3.7% last 3 year average. Recent Profitability : Nearl...
-
High Margins, Lower Price: Is This Merck stock’s Buying Window?
Merck (MRK) stock deserves your consideration. Why? Because you get monopoly-like high margins for a discounted price . Here is some data. Revenue Growth : Merck saw growth of 1.8% LTM and 3.7% last 3 year average. Recent Profitability : Nearl...
-
MRK Up 7.4% in One Day, Should You Buy The Stock?
We believe there is a near-equal mix of good and bad in MRK stock given its overall Moderate operating performance and financial condition. This is aligned with the stock’s Moderate valuation because of which we think it is Fairly Priced ....
-
MRK Capital Return Hits $91 Bil in 10 Years
In the last decade, Merck (MRK) has returned a notable $91 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the market’s bi...
-
After MRK’s 6.8% Climb in a Day, INVA Looks Like the Stronger Long-Term Play
Innoviva (INVA) offers superior revenue growth across key periods, better profitability, and relatively lower valuation vs Merck (MRK), suggesting you may be better off investing in INVA INVA’s quarterly revenue growth was 0.4%, vs. MRK&#...
-
S&P 500 Movers | Winners: PFE, MRK, DHR | Losers: ALB, MGM, COF
On Tuesday, September 30, a market-wide surge lifted the S&P 500 rising 0.41%, the Dow 30 rising 0.18%, and the Nasdaq 100 rising 0.28%. Gains were broad-based, though not every stock joined the rally. List of S&P 500 Winners ...
